to 4.74% in 2019. The increase of gross profit margin was mainly due to differences in product mix and the impact derived from adoption of USD as the Company’s functional currency which in resulting of
gross profit margin of 35.46%, while the same period last year the Company recorded gross profit margin of 34.89%, increase by 0.57% The increase in sales and gross profit margin in 1 and 2 make an
from non-social security patients which generated high margin and the increase of social security payment rate in the first half of year 2018. Moreover, the efficient cost management such as medicine
drop of 1.5% in the domestics. 2 Gross profits and gross profits margin Gross profits were THB 1,834 million, increased by THB 424 million or 30.1%, representing gross profit margin of 40.7%, an increase
current investment which is cash received from the private placement capital increase in Q1/2018. 2. Cost of sale , Profit margin In Q1/2018 the company had cost of sale Baht 78.13 million compare with the
same way of sales, but increase in less portion of sale increase. So it seem that this decreasing of cost of sales or increasing of gross margin was due to (a) the company had developed new formulas with
domestic and aboard sales as well as increase of agent commissions as selling through agents was higher. Net profit and Net profit margin For the 3nd quarter of 2018, the Company’s Net Profit was 2.73
54.5 1.1 Gross Profit Margin by Segment 29.1 28.3 25.6 25.7 0.1 33.5 27.1 (6.4) Gross Profit Margin Gross profit increase 2.0% QoQ from Baht 464.1 million to Baht 473.3 million. The increase Baht 9.2
volume. Gross Profit Margin Gross profit margin increased from 30.60% in 3Q17 to 39.18% in 3Q18. The main cause stemmed from a decrease in sugar and garlic prices, an increase in the proportion of revenue
second quarter of 2017. While the 6 month period of 2018, the Company’s gross profit showed 519.3 million baht. This represents the Gross Profit margin of 61.2%. An increase of the Company’s gross profit